We provide commercially focused, creative advice on obtaining, enforcing and exploiting intellectual property rights including patents, trade marks and designs to a wide range of clients who enjoy our straight forward approach and flexible working practices.
From the 25 May 2018, the GDPR will be fully enforceable throughout every member state within the European Union. Here we highlight key changes under the GDPR that SMEs in particular will need to comply with.
We are delighted to announce that we have now officially opened our first office in mainland Europe, in Munich, Germany. This cements our position as one of Europe’s leading specialist IP firms.
We are delighted to welcome Dydra Donath to the firm and to the partnership. Dydra, a highly experienced German national trade mark attorney with a doctorate in law joins our Munich Office.
We are now accepting applications from candidates for trainee patent attorney and trade mark attorney positions to start work in 2018. Vacancies are filled on a first come first served basis, so early application is recommended.
The Unitary Patent (UP) and Unified Patent Court (UPC) are due to come into entry in the near future and aim to bring a single patent right and single patent litigation forum to Europe.
t: +44 (0)20 7776 5300
t: +44 (0)117 945 1234
t: +44 (0)1223 420383
t: +44 (0)161 247 7722
t: +49 (0)89 244 459800
The U.S. Food and Drug Administration has approved the expanded use of AstraZeneca Plc’s cancer drug Lynparza. The new approval is for use in patients with metastatic breast cancer whose disease is associated with a mutation of the BRCA gene.
Partner Robert Watson will be visiting the United States Patent and Trademark Office (USPTO) on Monday 22 January 2018, as part of a FICPI delegation.